Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

359 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[A case of clonorchiasis complicated with the expansion of liver cyst].
Kominami Y, Aikata H, Hiramatsu K, Tanaka M, Naeshiro N, Nakahara T, Honda Y, Nagaoki Y, Murakami E, Miyaki D, Miki D, Kawaoka T, Takaki S, Hiraga N, Tsuge M, Serikawa M, Imamura M, Hyogo H, Kawakami Y, Takahashi S, Sasaki T, Chayama K. Kominami Y, et al. Among authors: tsuge m. Nihon Shokakibyo Gakkai Zasshi. 2013 Mar;110(3):456-64. Nihon Shokakibyo Gakkai Zasshi. 2013. PMID: 23459541 Japanese.
Two patients treated with simeprevir plus pegylated-interferon and ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation: case report.
Kawaoka T, Imamura M, Kan H, Fujino H, Fukuhara T, Kobayashi T, Honda Y, Naeshiro N, Hiramatsu A, Tsuge M, Hayes CN, Kawakami Y, Aikata H, Ochi H, Ishiyama K, Tashiro H, Ohdan H, Chayama K. Kawaoka T, et al. Among authors: tsuge m. Transplant Proc. 2015 Apr;47(3):809-14. doi: 10.1016/j.transproceed.2014.10.052. Transplant Proc. 2015. PMID: 25891736
IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma.
Kawaoka T, Aikata H, Takaki S, Hiramatsu A, Waki K, Hiraga N, Miki D, Tsuge M, Imamura M, Kawakami Y, Takahashi S, Ochi H, Tashiro H, Ohdan H, Chayama K. Kawaoka T, et al. Among authors: tsuge m. J Viral Hepat. 2011 Oct;18(10):e550-60. doi: 10.1111/j.1365-2893.2011.01468.x. Epub 2011 May 23. J Viral Hepat. 2011. PMID: 21914076
Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1.
Kosaka K, Imamura M, Hayes CN, Abe H, Hiraga N, Yoshimi S, Murakami E, Kawaoka T, Tsuge M, Aikata H, Miki D, Ochi H, Matsui H, Kanai A, Inaba T, Chayama K. Kosaka K, et al. Among authors: tsuge m. J Viral Hepat. 2015 Feb;22(2):158-65. doi: 10.1111/jvh.12271. Epub 2014 Jun 19. J Viral Hepat. 2015. PMID: 24943406 Clinical Trial.
Intracellular enhancement technique for gadoxetic acid-enhanced hepatobiliary-phase magnetic resonance imaging: evaluation of hepatic function.
Fonseca D, Nakamura Y, Higaki T, Maeda S, Nishihara T, Bito Y, Takizawa M, Kondo S, Higashino R, Morishita S, Akiyama Y, Fukuma S, Kawaoka T, Tsuge M, Oka S, Awai K. Fonseca D, et al. Among authors: tsuge m. Abdom Radiol (NY). 2025 Jan 31. doi: 10.1007/s00261-025-04817-y. Online ahead of print. Abdom Radiol (NY). 2025. PMID: 39888382
359 results